Your browser doesn't support javascript.
loading
Adjuvant therapy for renal cell carcinoma: 2023 Canadian Kidney Cancer Forum consensus statement.
Lalani, Aly-Khan A; Kapoor, Anil; Basappa, Naveen S; Bhindi, Bimal; Bjarnason, Georg A; Bosse, Dominick; Breau, Rodney H; Canil, Christina M; Cardenas, Luisa M; Castonguay, Vincent; Chavez-Munoz, Claudia; Chu, William; Dudani, Shaan; Graham, Jeffrey; Heng, Daniel Y C; Kollmannsberger, Christian; Lattouf, Jean-Baptiste; Morgan, Scott; Reaume, M Neil; Richard, Patrick O; Swaminath, Anand; Tanguay, Simon; Wood, Lori A; Lavallée, Luke T.
Afiliación
  • Lalani AA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada.
  • Kapoor A; St Joseph's Healthcare Hamilton, McMaster University, Hamilton, ON, Canada.
  • Basappa NS; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Bhindi B; Southern Alberta Institute of Urology, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
  • Bjarnason GA; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Bosse D; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Breau RH; Department of Surgery, University of Ottawa, Ottawa, ON, Canada.
  • Canil CM; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Cardenas LM; Department of Medical Oncology, Juravinski Cancer Centre, McMaster, Hamilton, ON, Canada.
  • Castonguay V; Centre de recherche du Centre Hospitalier Universitaire de Québec - Université Laval (CRCHUQc-UL), Centre de recherche sur le cancer (CRC) de l'Université Laval, Québec, QC, Canada.
  • Chavez-Munoz C; Vancouver Prostate Centre, University of British Columbia, Vancouver, BC, Canada.
  • Chu W; Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Dudani S; Department of Oncology, William Osler Health System, Brampton, ON, Canada.
  • Graham J; University of Manitoba, Winnipeg, MB, Canada.
  • Heng DYC; Department of Medical Oncology, Tom Baker Cancer Center, Calgary, AB, Canada.
  • Kollmannsberger C; BC Cancer - Vancouver Centre, Vancouver, BC, Canada.
  • Lattouf JB; Department of Surgery, University of Montreal, Montreal, QC, Canada.
  • Morgan S; Department of Radiation Oncology, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
  • Reaume MN; Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Richard PO; Department of Urology, Centre Hospitalier Universitaire de Sherbrooke and Centre de Recherche du CHUS, Sherbrooke, QC, Canada.
  • Swaminath A; Department of Radiation Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON, Canada.
  • Tanguay S; Division of Urology, Department of Surgery, McGill University, Montreal, QC, Canada.
  • Wood LA; Division of Medical Oncology, Dalhousie University, Halifax, NS, Canada.
  • Lavallée LT; Division of Urology and Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON, Canada.
Can Urol Assoc J ; 17(5): E154-E163, 2023 May.
Article en En | MEDLINE | ID: mdl-37185210
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Can Urol Assoc J Año: 2023 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline Idioma: En Revista: Can Urol Assoc J Año: 2023 Tipo del documento: Article País de afiliación: Canadá